Clinical trial
Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
NCT07200102 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 17, 2026
- Completion date
- March 31, 2031
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.